J F Toole
Affiliation: Wake Forest University School of Medicine
- Hyperbaric oxygen for stroke treatmentJames Toole
Department of Neurology, Wake Forest University School of Medicine Medical Center Boulevard, Winston Salem, NC 27157 1002, USA
Med Gas Res 1:4. 2011..ABSTRACT: This is an editorial for the inauguration of the Medical Gas Research and addresses a particular issue of using hyperbaric oxygen for stroke treatment...
- A pianist's recovery from strokeJames F Toole
Department of Neurology, Stroke Center, Wake Forest University School of Medicine, The Bowman Gray Campus, Medical Center Boulevard, Winston Salem, NC 27157 1068, USA
Arch Neurol 64:1184-8. 2007..To determine alternative neural pathways for restitution of piano playing after right hemispheric infarction causing left arm and hand paralysis...
- Vitamin intervention for stroke preventionJames F Toole
Stroke Research Center, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157 1068, USA
J Neurol Sci 203:121-4. 2002..The Vitamins to Prevent Stroke (VITATOPS) is a parallel study based in Australia with similar goals, and, hopefully, the data from the two will be comparable and supportive...
- Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trialJames F Toole
Stroke Research Center, Department of Neurology, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
JAMA 291:565-75. 2004..However the utility of homocysteine-lowering therapy to reduce that risk has not been confirmed by randomized trials...
- Statin treatment and adherence to national cholesterol guidelines after ischemic strokeB Ovbiagele
Stroke Center, Department of Neurology, UCLA School of Medicine, Los Angeles, CA, USA
Neurology 66:1164-70. 2006..The authors aimed to determine the rate of statin use, its predictors, and the achievement of national guideline target lipid goals among ischemic stroke survivors...
- Transcobalamin 2 variant associated with poststroke homocysteine modifies recurrent stroke riskF C Hsu
Department of Biostatistical Sciences, Wake Forest University School of Medicine, Winston Salem, NC, USA
Neurology 77:1543-50. 2011..We investigated genes for enzymes and cofactors in the Hcy metabolic pathway for association with Hcy and determined whether associated single nucleotide polymorphisms (SNPs) influenced recurrent stroke risk...
- Cigarette smoking and other risk factors for silent cerebral infarction in the general populationG Howard
Department of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, NC, USA
Stroke 29:913-7. 1998..This report focuses on the role of cigarette smoking and other risk factors for SCI in the general population...
- Association of diabetes, homocysteine, and HDL with cognition and disability after strokeGeorge C Newman
Department of Neurology, Albert Einstein Medical Center, 5401 Old York Road, Suite 300, Philadelphia, PA 19141, USA
Neurology 69:2054-62. 2007..To delineate factors associated with cognitive function following stroke and test the hypothesis that vascular risk factors associated with oxidative stress impair recovery...
- Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesisMark Fisher
Department of Neurology, University of Southern California School of Medicine, Los Angeles, Calif, USA
Stroke 36:253-7. 2005..To determine the relationship between ulceration, thrombus, and calcification of carotid artery atherosclerotic plaques and symptoms of ipsilateral or contralateral stroke...
- Plasma total homocysteine levels in stroke patients screened for the vitamin intervention for stroke prevention clinical trial in the era of folate fortificationHelmi L Lutsep
Oregon Stroke Center, OHSU, Portland, OR 97239, USA
Neuroepidemiology 26:45-51. 2006..06 overall, 0.0003 in the oldest age group). US levels were 0.39 micromol/l (95% CI: -0.08, 0.85) lower than in Canada. Neither fasting nor time since stroke affected the results...
- The changing risk factor profile of participants enrolled in a secondary stroke prevention trial: Vitamin intervention for stroke preventionVirginia J Howard
Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL 35294 0022, USA
Neuroepidemiology 27:222-9. 2006..To determine if the stroke risk factor profile of participants in a large, multicenter secondary stroke prevention trial changed over the recruitment period...
- Association between symptoms reported in a population questionnaire and future ischemic stroke: the ARIC studyLloyd E Chambless
Department of Biostatistics, School of Public Health, University of North Carolina, Chapel Hill, NC 27514, USA
Neuroepidemiology 23:33-7. 2004..9-4.1. Greater relative risk was found among younger individuals, women, African-Americans, persons not current smokers, and those with lower white blood cell count...
- Validation of homocyst(e)ine-lowering treatment in the era of folic acid fortification of cereal grainsM Rene Malinow
Arterioscler Thromb Vasc Biol 22:1051; author reply 1051. 2002
- Food (and vitamins) for thoughtJames F Toole
Neurology 58:1449-50. 2002
- Changes in plasma homocyst(e)ine in the acute phase after strokeVirginia J Howard
Department of Epidemiology and International Health, University of Alabama at Birmingham, Birmingham, Ala 35294 0022, USA
Stroke 33:473-8. 2002..Although the literature suggests that H(e) increases from the acute to the convalescent phase after a stroke, it is not known whether H(e) changes within the acute period...
- VITAMIN INTERVENTION FOR STROKE PREVENTION (VISP)James Toole; Fiscal Year: 2006..A supplemental research proposal for use of frozen plasma samples of our cohart for genetic and coogulation studies is in preparation. ..